Chemical Warfare

Aasted A, Darre E, Wulf HC. Mustard gas: clinical, toxicological, and mutagenic aspects based on modern experience. Ann Plast Surg 1987; 19 (4):330-333.

Altenkirch H, Stoltenburg-Didinger G, Koeppel C. The neurotoxicological aspects of the toxic oil syndrome (TOS) in Spain. Toxicology 1988; 49 (1):25-34.

Amitai Y, Almog S, Singer R, Hammer R, Bentur Y, Danon YL. Atropine poisoning in children during the Persian Gulf crisis: a national survey in Israel. JAMA 1992; 268 (5):630-632.

Andreassi L. Chemical warfare and the skin. Int J Dermatol 1991; 30 (4):252-253.

Ankney B. Iraq possessed large biological research program, UN team says. US Med 1992; 28:3, 40-41.

Anzueto A, de Lemos RA, Seidenfeld J, et al. Acute inhalation toxicity of soman and sarin in baboons. Fundam Appl Toxicol 1990; 14:676-687.

Balali M. Clinical and laboratory findings in Iranian fighters with chemical gas poisoning. Arch Belg 1984; 1984:254-259.

Barnaby F. Iran-Iraq war: The use of chemical weapons against the Kurds. Ambio 1988; 17 (6):407-408.

Barranco VP. Mustard gas and the dermatologist. Int J Dermatol 1991; 30 (10):684-686.

Bell IR, Warg-Damiani L, Baldwin CM, Walsh ME, Schwartz GEW. Self-reported chemical sensitivity and wartime chemical exposures in Gulf War veterans with and without decreased global health ratings. Mil Med 1998; 163 (11):725-732.

Benschop HP, van der Schans GP, Noort D, Fidder A, Mars-Groenendijk RH, de Jong LP. Verification of exposure to sulfur mustard in two casualties of the Iran-Iraq conflict. J Anal Toxicol 1997; 21 (4):249-251.

Black RM, Clark RJ, Read RW, Reid MTJ. Application of gas chromatography-mass spectrometry and gas chromatography-tandem mass spectrometry to the analysis of chemical warfare samples, found to contain residues of the nerve agent sarin, sulphur mustard and their degradation products. J Chromatogr 1994; 662:301-321.

Black RM, Read RW. Methods for the analysis of thiodiglycol sulphoxide, a metabolite of sulphur mustard, in urine using gas chromatography-mass spectrometry. J Chromatogr 1991; 558 (2):393-404.

Blanck RR. Trip report of meetings with coalition members of Operation Desert Storm/Desert Shield concerning reports of low level chemical warfare agent detection and health of their forces. Falls Church, VA: US Dept of the Army, Office of the Surgeon General; 1994.

Blodi FC. Mustard gas keratopathy. Int Ophthalmol Clin 1971; 11 (3):1-13.

Bondy SC. Bondy SC. Especial considerations for neurotoxicological research. Crit Rev Toxicol 1985; 14 (4):381-402.

Borak J, Sidell FR. Agents of chemical warfare: sulfur mustard. Ann Emerg Med 1992; 21 (3):303-308.

Borkan J, Reis S. Untoward effects of gas masks during the Persian Gulf War. N Engl J Med 1991; 325:582-583.

Bullman TA, Kang HK. The effects of mustard gas, ionizing radiation, herbicides, trauma, and oil smoke on US military personnel: the results of veteran studies. Annu Rev Public Health 1994; 15:69-90.

Burchfield JL, Duffy FH. Organophosphate neurotoxicity: chronic effects of sarin on the electroencephalogram of monkey and man. Neurobehav Toxicol Teratol 1982; 4:767-778

Burchfield JL, Duffy FH, Sim V. Persistent effect of sarin and dieldrin on the electroencephalogram of monkey and man. Toxicol Appl Pharmacol 1976; 35:365-379.

Cancio LC. Chemical casualty decontamination by medical platoons in the 82nd Airborne Division. Mil Med 1993; 158 (1):1-5.

Carjuzaa A, Carpentier JP. Myoresolution: organophosphorus nerve agents and chemical warfare agents: curare problems. Med Armees 1991; 19 (2):97-98.

Carlisle D. Gulf War: The chemical threat. Nurs Times 1991; 87 (7):16-17.

Crowell JA, Parker R, Bucci TJ, Dacre JC. Neuropathy target esterase in hens after sarin and soman. J Biochem Toxicol 1989; 4.

Dacre JC, Goldman M. Toxicology and pharmacology of the chemical warfare agent sulfur mustard. Pharmacol Rev 1996; 48 (2):289-326.

das Gupta S, Bass KN, Warnick JE. Interaction of reversible and irreversible cholinesterase inhibitors on the monosynaptic reflex in neonatal rats. Toxicol Appl Pharmacol 1989; 99:28-36.

Dienstbier Z. Late effects of use of nuclear and certain chemical weapons in man. Med War 1985; 1 (1):25-30.

Dunn MA, Sidell FR. Progress in medical defense against nerve agents. JAMA 1989; 262 (5):649-652.

Epstein Y, Linder N, Lubin D, Gale R, Gale J, Reichman B. The incubator as a chemical warfare protective device in neonatal intensive care units. Isr J Med Sci 1991; 27 (11-12):648-651.

Fullerton CS, Ursano RJ. Behavioral and psychological responses to chemical and biological warfare. Mil Med 1990; 155 (2):54-59.

Gazzard MF, Thomas DP. A comparative study of central visual field changes induced by sarin vapor and physostigmine eye drops. Exp Eye Res 1975; 20:15-21.

Glass N. From mustard gas to biowarfare�Congress tackles military medicine. Lancet 1998; 351 (9112):1340.

Goldman M, Dacre JC. Lewisite: its chemistry, toxicology, and biological effects. Rev Environ Contam Toxicol 1989; 110:75-115.

Goldsmith MF. Often thwarted treaty efforts leave chemical, biological weapons a still potent threat. JAMA 1991; 265 (6):705.

Goldstein BD, Fincher DR, Searle JR. Electrophysiological changes in the primary sensory neuron following subchronic soman and sarin: alterations in sensory receptor function. Toxicol Appl Pharmacol 1987; 91:55-64.

Gordon JJ, Inns RH, Johnson MK, et al. The delayed neuropathic effects of nerve agents and some other organophosphorus compounds. Arch Toxicol 1983; 52:71-82.

Gunderson CH, Lehmann CR, Sidell FR, Jabbari B. Nerve agents: a review. Neurology 1992; 42:946-950.

Gupta RC, Patterson GT, Dettbarn WD. Comparison of cholinergic and neuromuscular toxicity following acute exposure to sarin and VX in rats. Fundam Appl Toxicol 1991; 16:449-458.

Hajgar J. Biological monitoring of exposure to nerve agents. Br J Ind Med 1992; 49:648-653.

Heller O, Aldar Y, Vosk M, Shemer J. An argument for equipping civilian hospitals with a multiple respiratory system for a chemical warfare mass casualty situation. Isr J Med Sci 1991; 27:652-655.

Heyndrickx A, de Puydt H, Cordonnier J. Comparative study of two different field tests for the detection of yperite in the atmosphere, applied on biological samples of gased soldiers. Arch Belg 1984; Supplement:61-68.

Heyndrickx A, Heyndrickx B. Treatment of Iranian soldiers attacked by chemical and microbiological war gases. Riv Tossicol Sper Clin 1989; 19:3-6.

Heyndrickx A, Sookvanichsilp N, van den Heede M. Detection of trichothecene mycotoxins (Yellow Rain) in blood, urine, and faeces of Iranian soldiers treated as victims of a gas attack. Riv Tossicol Sper Clin 1989; 19:7-11.

Hodgson E. Clarification: chemical synergism. Environ Health Perspect 1995; 103 (11):986.

Hughes JN, Knight R, Brown RFR, Marrs TC. Effects of experimental sarin intoxication on the morphology of the mouse diaphragm: a light and electron microscopical study. Int J Exp Pathol 1991; 72:195-209.

Husain K, Vijayaraghavan R, Pant SC, Raza SK, Pandey KS. Delayed neurotoxic effect of sarin in mice after repeated inhalation exposure. J Appl Toxicol 1993; 13:143-145.

Institute of Medicine. Veterans at risk: the health effects of mustard gas and lewisite. In: Pechura C, Rall D, eds. Washington, DC: National Academy Press; 1993.

Institute of Medicine, Committee on the Evaluation of the Department of Defense Comprehensive Clinical Evaluation Program. Adequacy of the Comprehensive Clinical Evaluation Program: Nerve Agents. Washington, DC: National Academy Press, 1997.

Jacob WH, Friedl KE. Drug Delivery Systems for Chemical Defense. Army Research, Development, and Acquisition Bulletin; 1990:14-16.

Jenkins RA, Buchanen MV, Merriweather R, Ilgner RH, Gayle TM, Watson AP. Movement of chemical warfare agent stimulants through porous media. J Hazardous Materials 1994; 37 (2):303-325.

Kadivar H, Adams SC. Treatment of chemical and biological warfare injuries: insights derived from the 1984 Iraqi attack on Majnoon Island. Mil Med 1991; 156 (4):171-177.

Kawabuchi M, Cintra WM, Despande SS, Albuquerque EX. Morphological and electrophysiological study of distal motor nerve fiber degeneration and sprouting after irreversible cholinesterase inhibition. Synapse 1991; 8:218-228.

Klein AK, Nasve ML, Goldman M. The effects of in vitro exposure to the neurotoxin sarin (GB) and soman (GD) on unscheduled DNA synthesis by rat hepatocytes. Toxicol Lett 1987; 38:239-249.

Knudson GB. Operation Desert Shield: medical aspects of weapons of mass destruction. Mil Med 1991; 156:267-271.

Kodavanti PRS, Mundy WR, Tilson HA, Harry GJ. Effects of selected neuroactive chemicals on calcium transporting systems in rat cerebellum and on survival of cerebellar granule cells. Fundam Appl Toxicol 1993; 21:308-316.

Kolka MA, Stephenson LA, Bruttig SP, Cadarette BS, Gonzalez RR. Human thermoregulation after atropine and/or pralidoxime administration. Aviat Space Environ Med 1987; 58:545-549.

Koslow EE. Would you go to war wearing this equipment? Armed Forces Journal International; May 1990:55-58.

Kuncl RW, George EB. Toxic neuropathies and myopathies. Curr Opin Neurol 1993; 6 (5):695-704.

Late M. Investigation of Gulf War chemical mix link planned. US Med 1996:11.

Little PJ, Scimeca JA, Martin BR. Distribution of [3H] diisopropyl-fluorophosphate, [3H] soman, [3H] sarin and their metabolites in mice brain. Drug Metab Dispos 1988; 16:515-520.

Liu DD, Watanabe HK, Ho IK, Hoskins B. Acute effects of soman, sarin, and tabun on cyclic nucleotide metabolism in rat striatum. J Toxicol Environ Health 1986; 19:23-32.

Macilain C. Study proves Iraq used nerve gas. Nature 1993; 363:3.

Malizia E, Smeriglio M, Milletti M, et al. Acute poisoning with chemical warfare agents: clinical observations on a group of patients and a follow-up after seven years. Riv Tossicol Sper Clin 1991; 21

(2-3):73-103.

Marino MT. Use of surrogate markers for drugs of military importance. Mil Med 1998; 163 (11):743-746.

Maurissen JP. Psychophysical testing in human populations exposed to neurotoxicants. Neurobehav Toxicol Teratol 1985; 7 (4):309-317.

McCarthy M. Studies link chemical exposure to Gulf War syndromes. Lancet 1997; 349 (9046):183.

Meisenberg BR, Melaragno AJ, Monroy RL. Granulocyte colony-stimulating factor (G-CSF) for mustard-induced bone marrow suppression. Mil Med 1993; 158 (7):470-474.

Mellor SG, Rice P, Cooper GJ. Vesicant burns. Br J Plast Surg 1991; 44 (6):434-437.

Mohamed-Ali H. Late lesions due to poison gas in survivors of the Iraqi poison warfare against the Kurdish people. Wien Med Wochenschr 1992; 142 (1):8-15.

Momeni AZ, Enshaeih S, Meghdadi M, Amindjavaheri M. Skin manifestations of mustard gas. A clinical study of 535 patients exposed to mustard gas. Arch Dermatol 1992; 128 (6):775-780.

Morita H, Yanagisawa N, Nakajima T, et al. Sarin poisoning in Matsumoto, Japan. Lancet 1995; 346:290-293.

Munro NB, Watson AP, Ambrose KR, Griffin GD. Treating exposure to chemical warfare agents: implications for health care providers and community emergency planning. Environ Health Perspect 1990; 89:205-215.

Murata K, Araki S, Yokoyama K, et al. Asymptomatic sequelae to acute sarin poisoning in the central and autonomic nervous system 6 months after the Tokyo subway attack. J Neurol 1997; 244 (10):601-606.

Murphy MR, Blick DW, Dunn MA, Fanton JW, Hartgraves SL. Diazepam as a treatment for nerve agent poisoning in primates. Aviat Space Environ Med 1993; 64 (2):110-115.

Murray VS, Volans GN. Management of injuries due to chemical weapons. BMJ 1991; 302:129-130.

Newman-Taylor AJ, Morris AJ. Experience with mustard gas casualties. Lancet 1991; 337:242.

O'Brien LS, Payne RG. Prevention and management of panic in personnel facing a chemical threat�lessons from the Gulf War. J R Army Med Corps 1993; 139 (2):41-45.

Orma PS, Middleton RK. Aerosolized atropine as an antidote to nerve gas. Ann Pharmacother 1992; 26

(7-8):937-938.

Pauser G, Aloy A, Carvana M, et al. Lethal intoxication by war gases on Iranian soldiers: therapeutic interventions on survivors of mustard gas and mycotoxin immersion. Arch Belg 1984; Supplement:341-351.

Pechura CM, Institute of Medicine. The health effects of mustard gas and lewisite. JAMA 1993; 269 (4):453.

Pennisi E. Chemicals behind Gulf War syndrome? Science 1996; 272 (5261):479-480.

Pour-Jafari H, Moushtaghi AA. Alterations of libido in gased Iranian men. Vet Hum Toxicol 1992; 34 (6):547.

Prakash UB. Chemical warfare and bronchoscopy. Chest 1991; 100 (6):1486.

Rall DP, Pechura CM. Effects on health of mustard gas. Nature 1993; 366:398-399.

Rees J, Harper P, Ellis F, Mitchell D. Mustard gas casualties. Lancet 1991; 337:430.

Rengstorff RH. Accidental exposure to sarin: vision effects. Arch Toxicol 1985; 56:201-203.

Requena L, Requena C, Sanchez M, et al. Chemical warfare: cutaneous lesions from mustard gas. J Am Acad Dermatol 1988; 19 (3):529-536.

Roberts J. Chemical weapons did not cause the Gulf War syndrome. BMJ 1995; 310:692.

Sandelowsky I, Simon GA, Bel P, Barak R, Vincze A. N1-(2-hydroxyethylthioethyl)-4-methyl imidazole (4-met-1-imid-thiodiglycol) in plasma and urine: a novel metabolite following dermal exposure to sulphur mustard. Arch Toxicol 1992; 66 (4):296-297.

Schaumburg HH, Spencer PS. Recognizing neurotoxic disease. Neurology 1987; 37 (2):276-278.

Seppalainen AM. Solvents and peripheral neuropathy. Prog Clin Biol Res 1986; 220:247-253.

Shapira Y, Bar Y, Berkenstadt H, Atsmon J, Danon YL. Outline of hospital organization for a chemical warfare attack. Isr J Med Sci 1991; 27:616-622.

Shemer J, Danon YL. Eighty years of the threat and use of chemical warfare: The medical-organizational challenge. Isr J Med Sci 1991; 27:608-612.

Sidel VW. Weapons of mass destruction: the greatest threat to public health. JAMA 1989; 262 (5):680-682.

Sidell FR, Borak J. Chemical warfare agents: II. Nerve agents. Ann Emerg Med 1992; 21 (7):865-871.

Sidell FR, Takafuji ET, Franz DR, eds. Medical Aspects of Chemical and Biological Warfare, 1997:229-241.

Singer AW, Jaax NK, Graham JS, McLeod Jr CG. Cardiomyopathy in soman and sarin intoxicated rats. Toxicol Lett 1987; 36:243-249.

Smith KJ, Hurst CG, Moeller RB, Skelton HG, Sidell FR. Sulfur mustard: Its continuing threat as a chemical warfare agent, the cutaneous lesions induced, progress in understanding its mechanism of action, its long-term health effects, and new developments for protection and therapy. J Am Acad Dermatol 1995; 32 (5):765-776.

Smith WJ, Dunn MA. Medical defense against blistering chemical warfare agents. Arch Dermatol 1991; 127 (8):1207-1213.

Sohrabpour H. Clinical manifestations of chemical agents on Iranian combatants during Iran-Iraq conflict. Arch Belg 1984; 291-297.

Thomas T, Kang H. Mortality and morbidity among Army Chemical Corps Vietnam veterans: A preliminary report. Am J Ind Med 1990; 18 (6):665-674.

US General Accounting Office. Operation Desert Storm: DoD Met Need for chemical Suits and Masks, but Longer Term Actions are Needed. Washington, DC: U S General Accounting Office, 1992.

US Presidential Advisory Committee on Gulf War Veterans' Illnesses, Lashof JC. Presidential Advisory Committee on Gulf War Veterans' Illnesse: Special Report. Washington, DC: The Committee: For sale by the U.S. G.P.O. Supt. of Docs., 1997:v, 69.

van Helden HP, Busker RW, Melchers BP, Bruijnzeel PL. Pharmacological effects of oximes: how relevant are they? Arch Toxicol 1996; 70 (12):779-786.

Verity MA. Neurotoxins and environmental poisons. Curr Opin Neurol Neurosurg 1992; 5 (3):401-405.

Wadman M. US claims of "no chemical links" to Gulf War illnesses under fire. Nature 1997; 385 (6613):187.

Warnick JE, Deshpande SB, Yang QZ, das Gupta S. Biphasic action of sarin on monosynaptic reflex in the neonatal rat spinal cord in vitro. Arch Toxicol 1993; 67:302-306.

Watson AP, Ambrose KR, Griffin GD, Leffingwell SS, Munro NB, Waters LC. Health effects of warfare agent exposure: implications for stockpile disposal. Environ Prof 1989; 11 (4):335-353.

Watson AP, Griffin GD. Toxicity of vesicant agents scheduled for destruction by the Chemical Stockpile Disposal Program. Environ Health Perspect 1992; 98:259-280.

Watson AP, Jones TD, Adams JD. Relative potency estimates of acceptable residues and reentry intervals after nerve agent release. Ecotoxicol Environ Saf 1992; 23 (3):328-342.

Watson AP, Jones TD, Griffin GD. Sulfur mustard as a carcinogen: application of relative potency analysis to the chemical warfare agents H, HD, and HT. Regul Toxicol Pharmacol 1989; 10 (1):1-25.

Wils ER, Hulst AG, de Jong AL, Verweij A, Boter HL. Analysis of thiodiglycol in urine of victims of an alleged attack with mustard gas. J Anal Toxicol 1985; 9 (6):254-257.

Wils ER, Hulst AG, van Laar J. Analysis of thiodiglycol in urine of victims of an alleged attack with mustard gas, Part II. J Anal Toxicol 1988; 2 (1):15-19.

Wormser U. Toxicology of mustard gas. Trends Pharmacol Sci 1991; 12 (4):164-167.

Yanagisawa N, ed. Report for Toxic Gas Attack in Matsumoto. Matsumoto, Japan: Matsumoto Local Medical Council; 1995.

Yokoyama K, Araki S, Murata K, et al. A preliminary study on delayed vestibulocerebellar effects of Tokyo subway sarin poisoning in relation to gender difference: frequency analysis of postural sway. J Occup Environ Med 1998; 40 (1):17-21.


Return to Table of Contents